Literature DB >> 7649278

Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells.

S Sugo1, N Minamino, H Shoji, K Kangawa, H Matsuo.   

Abstract

To elucidate the regulation mechanism of adrenomedullin (AM) production in blood vessels, we examined the effects of 30 substances on AM production in cultured rat vascular smooth muscle cells (VSMCs). Forskolin and 8-bromo-cAMP suppressed production and gene transcription of AM. Since VSMC expresses AM receptors coupled with adenylate cyclase, AM production may be regulated by intracellular cAMP concentration. Thrombin, vasoactive intestinal polypeptide and interferon-gamma also inhibited AM production, while angiotensin II, endothelin-1, bradykinin, substance P, adrenaline, phorbol ester and fetal calf serum stimulated AM production in VSMC. These results suggest that AM production is regulated by a variety of substances, indicating complex systems regulating AM production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649278     DOI: 10.1016/0014-5793(95)00769-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

Review 2.  Adrenomedullin, a Novel Target for Neurodegenerative Diseases.

Authors:  Hilda Ferrero; Ignacio M Larrayoz; Francisco J Gil-Bea; Alfredo Martínez; María J Ramírez
Journal:  Mol Neurobiol       Date:  2018-03-29       Impact factor: 5.590

3.  Adrenomedullin in rat follicles and corpora lutea: expression, functions and interaction with endothelin-1.

Authors:  Lei Li; Wai-Sum O; Fai Tang
Journal:  Reprod Biol Endocrinol       Date:  2011-08-09       Impact factor: 5.211

4.  The Role of Adrenomedullin in Cardiovascular Response to Exercise - A Review.

Authors:  Krzysztof Krzeminski
Journal:  J Hum Kinet       Date:  2016-10-14       Impact factor: 2.193

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.